科研项目:主持在研课题9项,总经费:133.74万元 1.NGF/TrkA调控神经递质分泌诱导滑膜FLS侵袭与促炎在糖尿病夏科氏关节病的分子作用机制研究,西安市卫健委,面上培育项目,2025ms10,2025-01至2026-12,8万. 2.北京大学人民医院,横向课题,2024PHB161,足踝部常见疾病手术质量标准化评估系统的研发及临床应用研究,2024-01至2026-12,10万,在研,主持 3.评价生物型接骨空心螺钉用于膝关节及踝关节等处骨折块的固定的安全性和有效性.项目编号:(2014)械001-GK 横向课题 2024-01至2026-01 药物/器械临床试验机构. 50.74万元 4.IL-6介导的炎症反应在糖尿病夏科氏关节病骨关节破坏中的作用机制研究. 项目编号:xzy012022130 自由探索与创新项目 2023-01至2024-12 西安交通大学. 10万元 5.踝关节炎发病机制与阶梯化防治关键技术.项目编号:XAYC210060 西安英才计划项目 2022-01至2024-12 中共西安市委组织部. 20万 6.柔韧性平足症的数字化评估与不同干预方式的疗效分析.项目编号:2021-SF025重点研发计划社发项目 2021-01至2022-12 陕西省科技厅. 7万 7.Wnt/β-连锁蛋白通过RANKL/OPG通路参与Charcot关节病发病的分子机制研究. 项目编号:2021ms07 面上项目 2022-01至2023-12 西安市卫健委. 8万 8.糖尿病夏科氏关节病(DCA)相关基因的筛选与验证.项目编号:2019114613YX001SF03(12) 科技计划项目 2020-10至2022-12 西安市科技局.5万 9.糖尿病性关节病的病理特征及与线粒体损伤的相关性研究. 项目编号:2017M613178 面上项目 2017-05至2020-03 国家博士后基金委.5万 10.夏科式关节病的病理特征及发病机制研究.项目编号:2017BSHQYXMZZ13 博士后项目 2018-01至2020-12 陕西省人力资源与社会保障厅.10万 学术论文: 2022年1月—今的发表文章:(44篇,sci:34 篇,中文核心:10篇) 1.Bioactive protein/polysaccharide hydrogel functionalized bone implants surface for enhanced osteogenesis[J].International Journal of Biological Macromolecules, 2025, 317.DOI:10.1016/j.ijbiomac.2025.144626.共同通讯 2.HVAngleEst: A Dataset for End-to-end Automated Hallux Valgus Angle Measurement from X-Ray Images[J].Scientific Data, 2025, 12(1).DOI:10.1038/s41597-025-05261-9. 通讯作者 3.Associations of comprehensive dietary antioxidant index with postmenopausal femur bone mineral density and osteoporosis: data from the national health and nutrition examination survey.FRONTIERS IN NUTRITION,2025,通讯作者 4.Three-Plane Calcaneal Osteotomy With Joint Preservation vs Subtalar Arthrodesis to Treat Painful Calcaneal Fracture Malunions.FOOT & ANKLE INTERNATIONAL,2025,通讯作者 5.3D Printed Bioactive Mechanical-Adaptive Polyetheretherketone Implants with Non-Invasive Tracking for Immunomodulatory Osseointegration.ADVANCED HEALTHCARE MATERIALS.2025,共同通讯 6.DNA甲基化在骨关节炎发生,进展,诊断及治疗中作用的研究进展[J].中华解剖与临床杂志, 2025, 30(06):429-434.DOI:10.3760/cma.j.cn101202-20240924-00282.通讯作者 7.距骨骨软骨损伤诊治的研究进展[J].中华解剖与临床杂志, 2025, 30(07):498-503.DOI:10.3760/cma.j.cn101202-20240918-00275.通讯作者 8.Radiologic and Clinical Outcomes of the Dovetailed Notch Scarf Osteotomy for Correcting the First Metatarsal Pronation in Moderate to Severe Hallux Valgus Deformity: A Comparative Study. Foot Ankle Int, 2024, 45(7):728-736. 共同通讯 9.Radiological characteristics and injury mechanism of Logsplitter injury: a descriptive and retrospective study. BMC Musculoskelet Disord. 2024 Jul 26;25(1):585. 通讯作者 10.Plant-Derived Exosome-Like Nanoparticles: Emerging Nanosystems for Enhanced Tissue Engineering. Int J Nanomedicine. 2024, 19: 1189-1204. 通讯作者 11.Enhancing angiogenesis: Innovative drug delivery systems to facilitate diabetic wound healing. Biomed Pharmacother. 2024 Jan; 170:116035. 通讯作者 12.Integration of miRNA in exosomes and single-cell RNA-seq profiles in endemic osteoarthritis, Kashin-Beck disease. Biofactors. 2023 Dec 29. 共同通讯 13.Comparative Analysis of Gut Microbiota from Rats Induced by Se Deficiency and T-2 Toxin. Nutrients. 2023 Dec 7;15(24):5027. 共同通讯 14.Bioprinting-Enabled Biomaterials: A Cutting-Edge Strategy for Future Osteoarthritis Therapy. Int J Nanomedicine. 2023 Nov 1;18:6213-6232. 通讯作者 15.Musculoskeletal Ultrasound for the Diagnosis of Plantar Fasciitis: An Accuracy and Diagnostic Yield Study. Int J Gen Med. 2023 Oct 25;16:4765-4771. 共同通讯 16.Integrative analysis of miRNA in cartilage-derived extracellular vesicles and single-cell RNA-seq profiles in knee osteoarthritis. Arch Biochem Biophys. 2023 Oct 15;748:109785. 共同通讯 17.Therapeutics of osteoarthritis and pharmacological mechanisms: A focus on RANK/RANKL signaling. Biomed Pharmacother. 2023 Nov;167:115646. 通讯作者 18.Modified hindfoot alignment radiological evaluation and application in the assessment of flatfoot. BMC Musculoskeletal Disorders, 2023, 24: 683. 通讯作者 19.Biomaterial-based scaffolds in promotion of cartilage regeneration: Recent advances and emerging applications. J Orthop Translat, 2023, 41: 54-62. 通讯作者 20.Harnessing exosomes as cutting-edge drug delivery systems for revolutionary osteoarthritis therapy. Biomed Pharmacother. 2023 Sep; 165: 115135. 通讯作者 21.Changes in the subtalar joint alignment after supramalleolar osteotomy for varus ankle arthritis. Foot Ankle Surg. 2023 Aug;29(6):475-480. 共同通讯 22.Altered gut microbiome profile in patients with knee osteoarthritis. Front Microbiol. 2023 May 12;14:1153424. 通讯作者 23.Cartilage Damage Pathological Characteristics of Diabetic Neuropathic Osteoarthropathy. Anal Cell Pathol (Amst). 2023 May 8; 2023: 7573165. 通讯作者 24.The Prevalence of Kashin-Beck Disease in China: a Systematic Review and Meta-analysis. Biol Trace Elem Res. 2023 Jul;201(7): 3175-3184. 通讯作者 25.Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective. Front Pharmacol. 2023 Apr 12;14:1160278. 通讯作者 26.经后外侧“安全区”行平行螺钉内固定治疗HawkinsⅠ-Ⅲ型距骨颈骨折疗效分析. 中国修复重建外科杂志, 2023, 37(11): 1347-1352. 通讯作者 27.足踝部糖尿病夏科神经性关节病的临床诊治进展. 中国修复重建外科杂志, 2023, 37(11): 1438-1443. 通讯作者 28.踝上截骨术治疗内翻型踝关节炎的有效性与危险因素分析. 中国修复重建外科杂志, 2023, 37(7): 788-795. 通讯作者 29.The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies. Front Endocrinol. 2022, 13: 1063815. 通讯作者 30.Differential expression of cyclins CCNB1 and CCNG1 is involved in the chondrocyte damage of kashin-beck disease. Front Genet. 2022, 13: 1053685. 共同通讯 31.Abnormal expression of TSG-6 disturbs extracellular matrix homeostasis in chondrocytes from endemic osteoarthritis. Front Genet. 2022. 18, 13: 1064565. 通讯作者 32.Fibronectin-1 is a dominant mechanism for rheumatoid arthritis via the mediation of synovial fibroblasts activity. Front Cell Dev Biol, 2022, 10: 1010114.通讯作者 33.Interaction between N6-methyladenosine and autophagy in the regulation of bone and tissue degeneration. Front Bioeng Biotechnol, 2022, 10: 978283. 通讯作者 34.Serum proteomic analysis of differentially expressed proteins and pathways involved in the mechanism of endemic osteoarthritis. Mol Omics. 2022, 18(8):745-753. 通讯作者 35.Supramalleolar Osteotomy vs Arthrodesis for the Treatment of Takakura 3B Ankle Osteoarthritis. Foot Ankle Int. 2022, 43(9): 1185-1193. 通讯作者 36.Closed reduction and posterior percutaneous internal fixation for simple displaced talar neck fracture: a retrospective comparative study. Int Orthop, 2022 Sep; 46(9): 2135-2143. 通讯作者 37.The Biological Interaction of SARS-CoV-2 Infection and Osteoporosis: A Preliminary Study. Front Cell Dev Biol, 2022, 10: 917907. 通讯作者 38.The Status of Selenium and Zinc in the Urine of Children From Endemic Areas of Kashin-Beck Disease Over Three Consecutive Years. Front Nutr, 2022 Apr 8; 9: 862639. 通讯作者 39.Triplane osteotomy combined with talar non-weight-bearing area autologous osteochondral transplantation for osteochondral lesions of the talus. BMC Musculoskeletal Disorders, 2022, 23: 79. 通讯作者 40.内踝三平面截骨骨软骨移植治疗距骨软骨病[J]. 中国矫形外科杂志, 2022, 30(15): 1426-1429. 通讯作者 41.青少年柔韧性平足症的诊断与治疗进展[J].中国骨与关节损伤杂志, 2022, 37(10): 1117-1120. 通讯作者 42.拇外翻患者第一跖骨旋转的相关研究进展[J]. 中华解剖与临床杂志, 2022, 27(8): 591-595. 通讯作者 43.三平面截骨保关节手术治疗跟骨关节内骨折畸形愈合的疗效分析 [J] . 中华创伤骨科杂志, 2022, 24(4) : 293-298. 通讯作者 44.高糖环境对软骨细胞RANKL/OPG表达的影响[J].实用骨科杂志, 2022, 28(02): 131-134, 通讯作者 获 奖: 科技奖励: 1.陕西高等学校科学技术研究优秀成果一等奖:系统流行病学统计理论与方法.(第二完成人)2024年 2.陕西省科学技术进步奖二等奖:踝关节炎的阶梯化防治关键技术.(第二完成人)2021年 3.陕西省科学技术进步奖三等奖:前足畸形的规范化治疗和关键技术推广.(第四完成人)2023年 荣誉: 1.2024:西安市红会医院“高层次人才” 2.2024:西安医学院“优秀硕士研究生导师” 3.2022:西安市委组织部“地方级领军人才(C类高层次人才)” 4.2022:西安市红会医院“优秀科技工作者” 5.2022:西安市红会医院“优秀党务工作者” 6.2021:西安市红会医院“医联体巡讲活动先进个人” 7.2021:西安市红会医院“研究生教学先进个人” 8.2021:西安市英才计划“菁英创新人才” 9.2021:西安市红会医院“高层次人才” 10.2020:第七届西安市“青年科技人才奖” 11.2020:西安市红会医院“中青年领军人才” 12.2020:西安医学院“优秀教师” |